Centinel Spine has received approval from the US Food and Drug Administration (FDA) for its posterior cervical thoracic stabilization system, Altos.
The company has developed the system for use in either the lateral masses of the cervical spine or the pedicles of the cervical-thoracic spine.
Centinel Spine chairman and CEO John Viscogliosi said: "Centinel Spine is dedicated to developing products that address surgical needs, anatomical challenges and surgeon requirements.
"We look forward to seeing the successful clinical outcomes and evidence that Altos was designed to achieve."
The low profile and stabilization system is said to provide both fully threaded and shank polyaxial screws with 80 degrees of freedom for simple insertion in the spinal anatomies.
In addition, the system provides laminar hooks, connectors, straight and curved rods for customizable constructs.
The company also markets Stalif product portfolio, including Stalif C, Stalif C-Ti, Midline II and Midline II-Ti.
In June 2015, the firm received FDA approval for Stalif Midline, Midline II and Midline II-Ti (Ti-active) devices for use with allogeneic bone graft in lumbar spinal fusion procedures.
In late 2014, the company received allogeneic clearance for its Stalif C and Stalif C-Ti devices for use in cervical fusion (ACDF) procedures.
Image: Centinel Spine’s Altos posterior cervical thoracic stabilization system received FDA approval. Photo: courtesy of Centinel Spine, Inc.